4//SEC Filing
Lutz Robert Matthew 4
Accession 0001104659-22-033320
CIK 0001420720other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:12 PM ET
Size
5.9 KB
Accession
0001104659-22-033320
Insider Transaction Report
Form 4
iBio, Inc.IBIO
Lutz Robert Matthew
See Remarks
Transactions
- Sale
Common Stock
2022-03-10$0.35/sh−24,625$8,510→ 207,375 total
Footnotes (2)
- [F1]The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3410 to $0.3481 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
iBio, Inc.
CIK 0001420720
Entity typeother
Related Parties
1- filerCIK 0001786203
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:12 PM ET
- Size
- 5.9 KB